{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T02:51:51Z","timestamp":1785466311847,"version":"3.56.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T00:00:00Z","timestamp":1641340800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-021-00601-5","type":"journal-article","created":{"date-parts":[[2022,1,5]],"date-time":"2022-01-05T12:03:26Z","timestamp":1641384206000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Genomic landscape of hyperleukocytic acute myeloid leukemia"],"prefix":"10.1038","volume":"12","author":[{"given":"Laetitia","family":"Largeaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1084-2781","authenticated-orcid":false,"given":"Sarah","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"B\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Tavitian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muriel","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Dufrechou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na\u00efs","family":"Prade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Vergez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0950-979X","authenticated-orcid":false,"given":"Jean Baptiste","family":"Rieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Luquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Sarry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Huguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1878-9129","authenticated-orcid":false,"given":"V\u00e9ronique","family":"De Mas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Delabesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3332-4525","authenticated-orcid":false,"given":"Christian","family":"R\u00e9cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,5]]},"reference":[{"key":"601_CR1","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.1182\/blood-2014-10-551507","volume":"125","author":"C Rollig","year":"2015","unstructured":"Rollig C, Ehninger G. How I treat hyperleukocytosis in acute myeloid leukemia. Blood 2015;125:3246\u201352.","journal-title":"Blood"},{"key":"601_CR2","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1038\/s41375-020-0783-3","volume":"34","author":"M Stahl","year":"2020","unstructured":"Stahl M, Shallis RM, Wei W, Montesinos P, Lengline E, Neukirchen J, et al. Management of hyperleukocytosis and impact of leukapheresis among patients with acute myeloid leukemia (AML) on short- and long-term clinical outcomes: a large, retrospective, multicenter, international study. Leukemia 2020;34:3149\u201360.","journal-title":"Leukemia"},{"key":"601_CR3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"H Dohner","year":"2017","unstructured":"Dohner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Buchner T, et al. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood 2017;129:424\u201347.","journal-title":"Blood"},{"key":"601_CR4","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2016.71.2208","volume":"35","author":"L Bullinger","year":"2017","unstructured":"Bullinger L, Dohner K, Dohner H. Genomics of Acute Myeloid Leukemia Diagnosis and Pathways. J Clin Oncol. 2017;35:934\u201346.","journal-title":"J Clin Oncol"},{"key":"601_CR5","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","volume":"374","author":"E Papaemmanuil","year":"2016","unstructured":"Papaemmanuil E, Gerstung M, Bullinger L, Gaidzik VI, Paschka P, Roberts ND, et al. Genomic Classification and Prognosis in Acute Myeloid Leukemia. N. Engl J Med. 2016;374:2209\u201321.","journal-title":"N. Engl J Med"},{"key":"601_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/ejh.13073","volume":"101","author":"FM Tien","year":"2018","unstructured":"Tien FM, Hou HA, Tsai CH, Tang JL, Chen CY, Kuo YY, et al. Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients. Eur J Haematol. 2018;101:86\u201394.","journal-title":"Eur J Haematol"},{"key":"601_CR7","doi-asserted-by":"publisher","first-page":"988","DOI":"10.3324\/haematol.2017.184267","volume":"103","author":"S Bertoli","year":"2018","unstructured":"Bertoli S, Picard M, Berard E, Griessinger E, Larrue C, Mouchel PL, et al. Dexamethasone in hyperleukocytic acute myeloid leukemia. Haematologica 2018;103:988\u201398.","journal-title":"Haematologica"},{"key":"601_CR8","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"601_CR9","doi-asserted-by":"crossref","unstructured":"Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 2018:201178.","DOI":"10.1101\/201178"},{"key":"601_CR10","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1182\/blood.2019002697","volume":"135","author":"K D\u00f6hner","year":"2020","unstructured":"D\u00f6hner K, Thiede C, Jahn N, Panina E, Gambietz A, Larson RA, et al. Impact of NPM1\/FLT3-ITD genotypes defined by the 2017 European LeukemiaNet in patients with acute myeloid leukemia. Blood 2020;135:371\u201380.","journal-title":"Blood"},{"key":"601_CR11","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/s41375-020-0972-0","volume":"34","author":"M Tambe","year":"2020","unstructured":"Tambe M, Karjalainen E, V\u00e4h\u00e4-Koskela M, Bulanova D, Gjertsen BT, Kontro M, et al. Pan-RAF inhibition induces apoptosis in acute myeloid leukemia cells and synergizes with BCL2 inhibition. Leukemia 2020;34:3186\u201396.","journal-title":"Leukemia"},{"key":"601_CR12","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1158\/1078-0432.CCR-17-1259","volume":"23","author":"L Simon","year":"2017","unstructured":"Simon L, Lavall\u00e9e VP, Bordeleau ME, Krosl J, Baccelli I, Boucher G, et al. Chemogenomic Landscape of RUNX1-mutated AML Reveals Importance of RUNX1 Allele Dosage in Genetics and Glucocorticoid Sensitivity. Clin Cancer Res. 2017;23:6969\u201381.","journal-title":"Clin Cancer Res"},{"key":"601_CR13","doi-asserted-by":"publisher","first-page":"623952","DOI":"10.3389\/fonc.2021.623952","volume":"11","author":"C R\u00e9cher","year":"2021","unstructured":"R\u00e9cher C. Clinical Implications of Inflammation in Acute Myeloid Leukemia. Front Oncol. 2021;11:623952.","journal-title":"Front Oncol"},{"key":"601_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.leukres.2018.02.015","volume":"68","author":"C Saillard","year":"2018","unstructured":"Saillard C, Elkaim E, Rey J, d\u2019Incan E, Charbonnier A, Etienne A, et al. Early preemptive ICU admission for newly diagnosed high-risk acute myeloid leukemia patients. Leuk Res. 2018;68:29\u201331.","journal-title":"Leuk Res"},{"key":"601_CR15","doi-asserted-by":"crossref","unstructured":"Bewersdorf JP, Zeidan AM. Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments? Cells. 2020;9:2310.","DOI":"10.3390\/cells9102310"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00601-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00601-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T18:28:10Z","timestamp":1669919290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-021-00601-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,5]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["601"],"URL":"https:\/\/doi.org\/10.1038\/s41408-021-00601-5","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,5]]},"assertion":[{"value":"26 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Christian R\u00e9cher: Research grants (my institution): Abbvie, Amgen, Novartis, BMS-Celgene, Jazz Pharma, Agios, Daiichi-Sankyo, Astellas, Roche, MaatPharma, Iqvia. Advisory boards: Abbvie, Janssen, Jazz Pharma, Daiichi-Sankyo, Astellas, Novartis, Celgene, Takeda, Roche, Otsuka, Macrogenics, Pfizer; Sarah Bertoli: advisory role for Jazz Pharmaceuticals, Daiichi-Sankyo, Sanofi, Astellas and BMS; Fran\u00e7ois Vergez: research grants from Pierre Fabre and Roche; is an advisor for Astellas and Amgen; Fran\u00e7oise Huguet: consultancy Novartis, Pfizer, Incyte; honoraria Amgen, Servier; Isabelle Luquet: advisory role for Jazz Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4"}}